MeiraGTx Holdings (MGTX) Non-Current Debt (2021 - 2025)
MeiraGTx Holdings (MGTX) reported Non-Current Debt of $49.7 million for Q4 2025, down 32.14% on a YoY basis from $73.2 million in Q4 2024, and down 32.65% quarter-over-quarter from $73.8 million in Q2 2025.
MeiraGTx Holdings (MGTX) Non-Current Debt (2021 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Non-Current Debt for 5 years, with the latest figure at $49.7 million in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Debt fell 32.14% year-over-year to $49.7 million; the trailing twelve-month figure through Dec 2025 stood at $49.7 million (down 32.14% YoY), and the FY2025 full-year result was $49.7 million, down 32.14% from the prior year.
- Non-Current Debt for Q4 2025 stood at $49.7 million, down from $73.8 million in the prior quarter.
- The five-year high for Non-Current Debt was $73.8 million in Q2 2025, with the low at $304000.0 in Q2 2022.
- Historically, Non-Current Debt has averaged $53.0 million across 5 years, with a median of $71.7 million in 2023.
- Annual changes were most pronounced in 2023 — Non-Current Debt soared 23443.09% — and 2025, when it plunged 32.14%.
- MeiraGTx Holdings' Non-Current Debt stood at $953000.0 in 2021, then surged by 7353.62% to $71.0 million in 2022, then grew by 1.53% to $72.1 million in 2023, then grew by 1.53% to $73.2 million in 2024, then plunged by 32.14% to $49.7 million in 2025.
- The last three Non-Current Debt figures came in at $49.7 million (Q4 2025), $73.8 million (Q2 2025), and $73.5 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 49.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.69 Mn |
| Dec 31, 2025 | 49.69 Mn |
| Jun 30, 2025 | 73.77 Mn |
| Jun 30, 2025 | 73.77 Mn |
| Mar 31, 2025 | 73.50 Mn |
| Mar 31, 2025 | 73.50 Mn |
| Dec 31, 2024 | 73.22 Mn |
| Dec 31, 2024 | 73.22 Mn |
| Sep 30, 2024 | 72.94 Mn |
| Sep 30, 2024 | 72.94 Mn |
| Jun 30, 2024 | 72.67 Mn |
| Jun 30, 2024 | 72.67 Mn |
| Mar 31, 2024 | 72.39 Mn |
| Mar 31, 2024 | 72.39 Mn |
| Dec 31, 2023 | 72.12 Mn |
| Dec 31, 2023 | 72.12 Mn |
| Sep 30, 2023 | 71.84 Mn |
| Sep 30, 2023 | 71.84 Mn |
| Jun 30, 2023 | 71.57 Mn |
| Jun 30, 2023 | 71.57 Mn |